Searching for Medical, New Tech, Green Energy and Gold. Embrace small caps w/ potential value before they morph into niche growth stocks w/ expanding market share and escalating earnings. Would prefer buying under $10 per share and then holding until discovered by sharks, daytraders or Buyout offers. Most investments are sheltered under IRA or ERSP Rollover tax schedules. Trading horizon may be as long as three-five years. Tend to Buy & Hold too long. Sometimes will give up on a 'Sleeper' and Sell for a Taxtime Capital Loss. No Options or Derivatives considered.
PLEASE SEE WEBSITE FOR FULL DISCLAIMER: WWW.PUMPSTOPPER.COM
I produce high quality, original research free of charge for the public good. Please see the website for more information, and subscribe to The Pump Stopper email list to receive free, high quality research reports before the rest.
I am always committed to publishing the accurate truth. If you are involved with a company that has been mentioned in a report and find any factual errors, please submit a dispute to Seeking Alpha and it will be reviewed.
If you have any tips on companies misleading investors, please submit them on The Pump Stopper website. I always welcome collaboration and have absolute respect for your anonymity. There are multiple ways to submit documents anonymously, as outlined on the website, and I strongly recommend you send information this way.
And remember to always invest wisely.
Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com
Jonathan Moreland is the founder and Director of Research at InsiderInsights.com, which produces the weekly InsiderInsights Newsletter, and offers institutional strength, real-time insider data and analytics via a subscription Data Module and APIs. He is also principal of Insider Asset Management llc, a registered investment advisor in New York State, and a past contributor to TheStreet.com, Minyanville, and other financial outlets.
A fundamental analyst with an MBA in finance, Mr. Moreland identified insider data over 25 years ago as an excellent first screen to determine where to focus his research efforts. He is quoted frequently in the media for his insider analysis, and stock recommendations stemming from it. He is also author of Profit From Legal Insider Trading (Dearborn 2001), and has a new book due out with Wiley.
Mr. Moreland is currently on a mission to get investors to expect more from insider data than the commodity feeds they rely on from their Bloomberg terminals, Yahoo!Finance, and other financial websites.
Marc Chandler has been covering the global capital markets in one fashion or another for 25 years, working at economic consulting firms and global investment banks. A prolific writer and speaker he appears regularly on CNBC and has spoken for the Foreign Policy Association. In addition to being quoted in the financial press daily, Chandler has been published in the Financial Times, Foreign Affairs, and the Washington Post. In 2009 Chandler was named a Business Visionary by Forbes.
Marc's commentary can be found at his blog (www.marctomarket.com) and twitter www.twitter.com/marcmakingsense
My name is Phil Mause. I am a Senior Advisor with the Pacific Economics Group, focusing on energy, regulatory and valuation issues. I retired from 40 years of law practice earlier this year. I am a yield oriented investor and in the last two years, I have done reasonably well in junk bonds, BDCs, mortgage REITS, and dividend paying blue chip stocks. As an avocation, I dabble in stand up comedy.
David White is a software/firmware/marketing professional and a long time investor. He has worked in the networking field, the semiconductor equipment field, the mainframe computer field, and the pharmaceutical/scientific instrumentation field. He has bachelor's degrees in bioresource sciences and biochemistry from U.C. Berkeley. He is a former Ph.D. student in biochemistry. He has done significant graduate work in EECS and business at Stanford (through SITN) and UC Santa Cruz. He was awarded a Certificate in Advanced Software Systems (about 1/3 of an MS in EECS) by the Stanford Computer Science Department. He also took most of Stanford's undergraduate Computer Science curriculum.
I am an individual investor who has been actively involved in the healthcare and biotechnology space for over 15 years. I hold a PhD in the biomedical sciences and have worked in both large pharmaceutical and small biotech companies. I make investments based on the fundamentals of a company and if I believe they have a superior technology or products compared to the competition. I'm an investor who believes patience pays off.
Have been investing for myself and my family for over 50 years. Retired sociology professor who also started and sold 3 retail stores over my career in teaching. Since I am retired, i am looking for stocks that pay dividends and offer some growth to keep up with inflation.
Charles Lewis Sizemore, CFA is the Chief Investment Officer of Sizemore Capital Management LLC, a registered investment advisor. He has been a frequent guest on Bloomberg TV and Fox Business News, has been quoted in Barron’s Magazine, The Wall Street Journal, and The Washington Post and is a frequent contributor to Forbes Moneybuilder, GuruFocus, MarketWatch and InvestorPlace.com.
Charles holds a master’s degree in Finance and Accounting from the London School of Economics in the United Kingdom and a Bachelor of Business Administration in Finance with an International Emphasis from Texas Christian University in Fort Worth, Texas, where he graduated Magna Cum Laude and as a Phi Beta Kappa scholar.
I am a lawyer and assistant professor living in New York. My work focuses on the intersection of energy policy and the economic feasibility of energy pathways. In addition to Seeking Alpha, my articles on renewable energy have been published by media sites including US News & World Report, Newsweek, The Huffington Post, and IFL Science. From a financial perspective I cover a variety of energy companies ranging from renewable energy to fossil fuels. While I discuss legal issues relating to these companies on occasion, my articles do not provide legal advice and nothing that I write on Seeking Alpha should be considered as such.
My focus is on companies that fly under the radar but offer opportunities for investment success because these companies have built in catalysts, a management team that has a clear business plan and fundamentals in place for the catalysts to bear fruit.
My investments include well known stocks, but I write mostly about small cap or under followed stocks. I don't think that a portfolio should be built on solely the type of stock that I write about but I offer ideas for the part of a portfolio dedicated to catalytic investment.
I look for large hedge fund interest in relatively unknown companies and then research the underlying reason for this investment. Most often, the reason is a growth in market share and there is an underlying catalyst.
As a value driven investor, my investment approach is safe and cheap. I focus on investing in companies with extremely strong financial positions offering future growth at a discount. I take that same top-down approach and apply a synthesis of market implied growth rates in securities to isolate companies where existing assets of the business covers the market price. I closely monitor the underlying fundamentals of financial markets and the global economy.
Where my research typically diverges from convention is - incorporating a volatility based perspective to the fundamental analysis, enhancing the risk control in investing.
I provide economic analysis, market commentary and company-specific research. My general view is to operate a diversified basket of long-term investments in both equities and fixed income. I have a bachelor's degree in economics from San Diego State University (2007), eight years of publishing experience and over a decade of cumulative investment experience. I have been published in several newspapers and magazines, including The Wall Street Journal and Barron's.
Retired CPA who has been investing for roughly 30 years now. Have a great deal of experience within the bowels of publicly traded companies with deep understanding of accounting issues they face as well as how management teams communicate with shareholders.
Think B.I.G., by Bespoke Investment Group, provides some of the most original content and intuitive thinking on the Street. Founded by Paul Hickey and Justin Walters, formerly of Birinyi Associates and creators of the acclaimed TickerSense blog, Bespoke offers multiple products that allow anyone, from institutions to the most modest investor, to gain the data and knowledge necessary to make intelligent and profitable investment decisions. Along with running their Think B.I.G. finance blog, Bespoke provides timely investment ideas through its Bespoke Premium (http://bespokepremium.com/) subscription service and also manages money (http://bespokepremium.com/mm) for high net worth individuals.
Visit: Bespoke Investment Group (http://bespokeinvest.com/)
Dana Blankenhorn http://www.danablankenhorn.com has been a business journalist since 1978, and a futurist all his life.He warned about the coming Houston oil collapse in 1979. He began making a living on the Internet in 1985. He launched the first e-commerce daily for CMP in 1994, warned of the coming dot-bomb at a-clue.com in 1997 and began covering the Internet of Things in 2003.Along the way he's written for a host of newspapers, magazines, news services and Web sites. Most recently he was at TheStreet.com, covering technology and investments. He still has time for freelance assignments. He lives in Atlanta.
Andy Hecht is a sought-after commodity and futures trader, an options expert and analyst. He spent nearly 35 years on Wall Street, including two decades on the trading desk of Phillip Brothers, which became Salomon Brothers and ultimately part of Citigroup.
Over the past two decades, he has researched, structured and executed some of the largest trades ever made, involving massive quantities of precious metals and bulk commodities.
Andy understands the market in a way many traders can’t imagine. He’s booked vessels, armored cars, and trains to transport and store a broad range of commodities. And he’s worked directly with The United Nations and the legendary trading group Phibro.
Today, Andy remains in close contact with sources around the world and his network of traders.
“I have a vast Rolodex of information in my head… so many bull and bear markets. When something happens, I don’t have to think. I just react. History does tend to repeat itself over and over.”
His friends and mentors include highly regarded energy and precious metals traders, supply line specialists and international shipping companies that give him vast insight into the market.
Andy’s writing and analysis are on many market-based websites including CQG. Andy lectures at colleges and Universities. He also contributes to Traders Magazine. He consults for companies involved in producing and consuming commodities. Andy's biweekly radio show, The Commodities Hour with Andy Hecht, can be heard on Tuesdays and Thursdays from 5-6 PM EST on www.tfnn.com. Andy’s first book How to Make Money with Commodities, published by McGraw-Hill was released in 2013 and has received excellent reviews. Andy held a Series 3 and Series 30 license from the National Futures Association and a collaborator and strategist with hedge funds. Andy is the commodity expert for the website about.com and blogs on his own site technomentals.com.
Peter "Pej" Hamidi is a well known trader on Wall Street and Founder of InvestmentCapitalist.com. He is presently a Quantitative Proprietary Trader running a global macro portfolio. By presenting a unique global macro perspective of financial markets, technology and the geo-political landscape affecting market movements, the site is visited on a daily basis by some of the most respected fund managers around the world. Investment Capitalist also helps readers understand how the tape can be used to recognize automated market making algorithms that may be vulnerable to coordinated attacks from hedge funds or when the algo's themselves are about to wreak havoc on the markets. If you're still leaving elephant tracks because you use market orders to unwind or put on positions, then you've got a big target painted on your back that says "I'm lazy".
Investment Capitalist's founder, Peter (Pej) Hamidi has refined these skills over 19 years as a professional trader, starting at 17 when he became the youngest person in the history of FINRA to obtain his Series 7 license on his 1st attempt. A common mantra drilled into every trader is "mastering your trading platform like Hendrix, Gilmore or Stevie Ray mastered their guitars is a prerequisite to success". In a world where milliseconds make the difference between success and failure, where even the slightest edge is crucial, if you're still using a few hot key combinations for all of your trading, the concept of "predatory algorithms" has still not become clear to you. Lazy traders are so frustrated by predatory algorithms disguised as automated market makers that they take it out on their keyboards or workstations.
InvestmentCapitalist.com has rapidly become the focal point of thousands of Institutional and Buy-Side Traders looking for real color that moves markets. If you've wanted to learn how one develops and trades a global macro theme properly, Investment Capitalist puts a great deal of time into showing viewers insight into this approach. Preferring not to charge money like many subscription services who sell their ideas because they lack the resources to trade on them, Investment Capitalist chooses to share actionable market intelligence. This avoids the risk of herd behavior stampeding in and out of trade recommendations, which are often picked off by hedge funds who take the other side of the recommended trade knowing short-term demand from fast-money traders is finite and fickle. Investment Capitalist says what needs to be said and nothing more. Patience is a virtue, garnering your resources, listening to the tape, collecting market color; until the opportunity becomes clear at which point it's "all in or go home".
With a pulse on developing technologies in Bio-Pharma, Computer Sciences, Big Data Storage and Analysis, Business Process Automation, Cloud Based Computing, and the phenomenon of Social Media Marketing and Behavioral Sciences across Philosophy, Economics, Anthropology and Politics; Investment Capitalist is an unending treasure trove of knowledge.
I am a futurist with an MBA in Managing for Sustainability from Marlboro College a BS in Biology. I invest with one eye on Sustainability and the other on Value. Since achieving my MBA i have consistently beaten the Dow Industrials and the S&P 500.
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Senior Analyst at iREIT Forbes and Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, and Fox Business. He was the #1 contributing analyst on Seeking Alpha in 2014 (as ranked by TipRanks) and he is currently writing a book on the legendary investor Donald Trump.
Thomas has co-authored a book (The Intelligent REIT Investor) that is available on Amazon.
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College where he played basketball. He resides in South Carolina with his wife and kids.
Private investor seeks value with exponential growth potential. I share my opinions freely. Do your due diligence, seek professional advice if you feel you need it. I prefer to be long and highly concentrated as I take the time to pick winners.
A biopharma portfolio manager as well as a sell-side biotechnology analyst for the past 20 years. In 2005, formed the Lyons Share Group, providing independent healthcare research and consulting services to institutional portfolio managers with regard to investments in the sector that fit the market capitalzation and investment styles. MBA from the Fuqua School of Business, Duke University and a Chartered Financial Analyst.
I look for a change in sentiment that precedes the change in trend. Moments of "lag" in sentiment can provide superb entry points into special situations at a discount; and obversely, manic enthusiasm can provide an opportunity to go short.
I research the fundamentals, know what I am getting into, and go long or short accordingly. Technical studies of the market are also an active part of my trading. I have invested for 22 years.
Technology and business consultant, who invests in Canada Europe, Australia, and USA. Deep financial sector and financial services experience from both business and technology perspectives. A do-it-yourself income investor, who is always evaluating and seeking high-yield and long-term, long positions.
Founder of Slingshot Insights, a company that works to provide retail investors access to professional grade investment research tools not readily at their disposal. As a former analyst at a large hedge fund, I found that as I began trading individual stocks on my own, I missed the research tools available to me when I worked for a large institution. The company was born from this idea and my desire to have access to a resource like SI.
www.SlingshotInsights.com Join for free today and check out our cartoon where "Investor Man" Becomes the Smart Money (and explains what Slingshot Insights can do for your diligence process)
Prior to starting Slingshot Insights, I was an analyst at a large hedge fund where I focused on the pharmaceutical industry creating investment theses driven by primary research. I remain a very active investor in a variety of stocks.
Pharma and Healthcare Dimensions (PharmaAndHealth.com) offers senior-level decisionmakers a simple view of the complex health policy landscape.
Although we're active all over the landscape of health reform and healthcare policy, Pharma and Health focuses on matters touching the FDA, the Medicare program (CMS), and especially projects touching both those agencies. Coverage and reimbursement for high-cost medical products is a common theme, as is the marketplace impact of a government decision.
Eric Katz, JD, Founder and President, spent ten years as a senior-level manager and policy expert at Medicare headquarters, plus another ten years on pharmaceutical work including a stint as Executive Director of the US Advisory Committee on the FDA.
Mr. Katz, a pharmaceutical lawyer by training, advises senior pharma leaders and a range of investment and consulting experts. He tracks Washington developments, translates them, and connects the dots to the rest of the changing healthcare landscape.
Gravity Research is an organization composed of financial analysts with experience working at top investment banks and buyside firms as well as industry veterans who are experts in their fields. We engage in careful research on publicly traded companies that we believe offer compelling long or short investment opportunities, and present our best ideas to the public.